Advances in environmental and occupational respiratory diseases in 2009

Journal of Allergy and Clinical Immunology

Volumn 125, Issue 3, 2010, Pages 559-562

  Peden, David B ^a   Bush, Robert K ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

allergens; allergic diseases; complementary and alternative medicine; Environmental pollutants; immunotherapy; occupational asthma; respiratory viruses; vaccines

Indexed keywords

DNA VACCINE; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E;

ALLERGIC DISEASE; ALTERNATIVE MEDICINE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; DISEASE SEVERITY; DNA IMMUNIZATION; ENVIRONMENTAL DISEASE; ENVIRONMENTAL EXPOSURE; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; OCCUPATIONAL ASTHMA; POLLUTANT; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RISK REDUCTION; SENSITIZATION; SMOKING;

ANIMALS; COMPLEMENTARY THERAPIES; ENVIRONMENTAL EXPOSURE; HUMANS; HYPERSENSITIVITY; IMMUNOTHERAPY; LUNG DISEASES; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; RISK FACTORS;

EID: 77949265459     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2010.01.004     Document Type: Article

References (31)

1. Grönlund H., Adedoyin J., Commins S.P., Platts-Mills T.A.E., and van Hage M. The carbohydrate galactose-alpha-1,3-galactose is a major IgE-binding epitope on cat IgA. J Allergy Clin Immunol 123 (2009) 1189-1191
2. Mattsson L., Lundgren T., Everberg H., Larsson H., and Lidholm J. Prostatic kallikrein: a new major dog allergen. J Allergy Clin Immunol 123 (2009) 362-368
3. Ayuso R., Grishina G., Ibanez M.D., Blanco C., Carrillo T., Bencharitiwong R., et al. Sarcoplasmic calcium-binding protein is an EF-hand-type protein identified as a new shrimp allergen. J Allergy Clin Immunol 124 (2009) 114-120
4. Ohgiya Y., Arakawa F., Akiyama H., Yoshioka Y., Hayashi Y., Sakai S., et al. Molecular cloning, expression, and characterization of a major 38-kd cochineal allergen. J Allergy Clin Immunol 123 (2009) 1157-1162
5. Dykewicz M.S. Occupational asthma: current concepts in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 123 (2009) 519-528
6. Krop E.J.M., Heederik D.J.J., Lutter R., De Meer G., Aalberse R.C., Jansen H.M., et al. Associations between pre-employment immunologic and airway mucosal factors and the development of occupational allergy. J Allergy Clin Immunol 123 (2009) 694-700
7. Malo J.L., and Chan-Yeung M. Agents causing occupational asthma. J Allergy Clin Immunol 123 (2009) 545-550
8. Gill B.V., Rice T.R., Cartier A., Gautrin D., Neis B., Horth-Susin L., et al. Identification of crab proteins that elicit IgE reactivity in snow crab-processing workers. J Allergy Clin Immunol 124 (2009) 1055-1061
9. Maestrelli P., Boschetto P., Fabbri L.M., and Mapp C.E. Mechanisms of occupational asthma. J Allergy Clin Immunol 123 (2009) 531-542
10. Takeda N., Maghni K., Daigle S., L'Archeveque J., Castellanos L., Al Ramli W., et al. Long-term pathologic consequences of acute irritant-induced asthma. J Allergy Clin Immunol 124 (2009) 975-981
11. Smith A.M., and Bernstein D.I. Management of work-related asthma. J Allergy Clin Immunol 123 (2009) 551-557
12. Walgraffe D., Matteotti C., el Bakkoury M., Garcia L., Marchand C., Bullens D., et al. A hypoallergenic variant of Der p 1 as a candidate for mite allergy vaccines. J Allergy Clin Immunol 123 (2009) 1150-1156
13. Roesler E., Weiss R., Weinberger E.E., Fruehwirth A., Stoecklinger A., Mostbock S., et al. Immunize and disappear-Safety-optimized mRNA vaccination with a panel of 29 allergens. J Allergy Clin Immunol 124 (2009) 1070-1077
14. Hofmann A.M., Scurlock A.M., Jones S.M., Palmer K.P., Lokhnygina Y., Steele P.H., et al. Safety of a peanut oral immunotherapy protocol in children with peanut allergy. J Allergy Clin Immunol 124 (2009) 286-291
15. Jones S.M., Pons L., Roberts J.L., Scurlock A.M., Perry T.T., Kulis M., et al. Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol 124 (2009) 292-300
16. Maintz L., Bussmann C., Bieber T., and Novak N. Contribution of histamine metabolism to tachyphylaxis during the buildup phase of rush immunotherapy. J Allergy Clin Immunol 123 (2009) 701-703
17. Scranton S.E., Gonzalez E.G., and Waibel K.H. Incidence and characteristics of biphasic reactions after allergen immunotherapy. J Allergy Clin Immunol 123 (2009) 493-498
18. Ronmark E., Bjerg A., Perzanowski M., Platts-Mills T., and Lundback B. Major increase in allergic sensitization in schoolchildren from 1996 to 2006 in northern Sweden. J Allergy Clin Immunol 124 (2009) 357-363
19. Erwin E.A., Hosen J., Pollart S.M., Reid M.J., and Platts-Mills T.A. High-titer IgE antibody specific for pollen allergens in northern California is associated with both wheezing and total serum IgE. J Allergy Clin Immunol 123 (2009) 706-708
20. Balmes J.R., Earnest G., Katz P.P., Yelin E.H., Eisner M.D., Chen H., et al. Exposure to traffic: lung function and health status in adults with asthma. J Allergy Clin Immunol 123 (2009) 626-631
21. Zock J.P., Plana E., Anto J.M., Benke G., Blanc P.D., Carosso A., et al. Domestic use of hypochlorite bleach, atopic sensitization, and respiratory symptoms in adults. J Allergy Clin Immunol 124 (2009) 731-738
22. Lopez-Souza N., Favoreto S., Wong H., Ward T., Yagi S., Schnurr D., et al. In vitro susceptibility to rhinovirus infection is greater for bronchial than for nasal airway epithelial cells in human subjects. J Allergy Clin Immunol 123 (2009) 1384-1390
23. Rueff F., Przybilla B., Bilo M.B., Muller U., Scheipl F., Aberer W., et al. Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity. J Allergy Clin Immunol 124 (2009) 1047-1054
24. Pieretti M.M., Chung D., Pacenza R., Slotkin T., and Sicherer S.H. Audit of manufactured products: use of allergen advisory labels and identification of labeling ambiguities. J Allergy Clin Immunol 124 (2009) 337-341
25. Siebenhaar F., Degener F., Zuberbier T., Martus P., and Maurer M. High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study. J Allergy Clin Immunol 123 (2009) 672-679
26. Haselkorn T., Fish J.E., Zeiger R.S., Szefler S.J., Miller D.P., Chipps B.E., et al. Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study. J Allergy Clin Immunol 124 (2009) 895-902
27. Appleton S.L., Ruffin R.E., Wilson D.H., Taylor A.W., and Adams R.J. Cardiovascular disease risk associated with asthma and respiratory morbidity might be mediated by short-acting beta2-agonists. J Allergy Clin Immunol 123 (2009) 124-130
28. Sampson H.A. Role of complementary and alternative medicine in the field of allergy and clinical immunology. J Allergy Clin Immunol 123 (2009) 317-318
29. Engler R.J., With C.M., Gregory P.J., and Jellin J.M. Complementary and alternative medicine for the allergist-immunologist: where do I start?. J Allergy Clin Immunol 123 (2009) 309-316
30. Mainardi T., Kapoor S., and Bielory L. Complementary and alternative medicine: herbs, phytochemicals and vitamins and their immunologic effects. J Allergy Clin Immunol 123 (2009) 283-294
31. Li X.M., and Brown L. Efficacy and mechanisms of action of traditional Chinese medicines for treating asthma and allergy. J Allergy Clin Immunol 123 (2009) 297-306